Animal Science

Based upon HS Pharmaceuticals’ silicate-based nanoparticle technology, licensees of the HSX technology are developing ointments to help aid wound healing and possibly tumor reduction for the companion-pet and equine markets. These variations of the technology are anticipated to move into United States manufacturing and sales in Q3 2017, with European Union manufacturing and sales by…

Cosmetic, Beauty & Personal Care

The cosmetic, beauty and personal care markets in both the United States and overseas offer a fantastic potential for HS Pharmaceuticals’ silicate-based nanoparticle technology. Current licensees of the HSX technology have coalesced a seasoned industry team with expertise in both physician-dispensed and mass market brands. Working with Princeton Consumer Research and JMR Development, these teams…